Epidemiology of bladder cancer.
D000367:Age Factors; D000588:Amines / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001530:Belgium; D002274:Carcinogens, Environmental / Q000009:adverse effects; D002295:Carcinoma, Transitional Cell / Q000453:epidemiology*; D003069:Coffee / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D004032:Diet; D005060:Europe; D006801:Humans; D007564:Japan; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D009784:Occupational Diseases / Q000139:chemically induced; D009930:Organic Chemicals; D010615:Phenacetin / Q000009:adverse effects; D012306:Risk; D012907:Smoking; D013549:Sweetening Agents / Q000009:adverse effects; D014481:United States; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D014552:Urinary Tract Infections / Q000150:complications
D000588:Amines; D000970:Antineoplastic Agents; D002274:Carcinogens, Environmental; D003069:Coffee; D009930:Organic Chemicals; D013549:Sweetening Agents; C043085:chlorphanazin; D003520:Cyclophosphamide; D010615:Phenacetin